Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer

Dino Amadori, Rosella Silvestrini, Mario De Lena, Francesco Boccardo, Andrea Rocca, Emanuela Scarpi, Francesco Schittulli, Mario Brandi, Roberta Maltoni, Patrizia Serra,

Breast Cancer Research and Treatment · 2010 · 21 citations · 30 references

DOIFull text

Open access

Concepts

References

30